These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23800517)

  • 1. Determinants of bone marrow adiposity: the modulation of peroxisome proliferator-activated receptor-γ2 activity as a central mechanism.
    Sadie-Van Gijsen H; Hough FS; Ferris WF
    Bone; 2013 Oct; 56(2):255-65. PubMed ID: 23800517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow.
    Baek K; Cho JY; Hwang HR; Kwon A; Lee HL; Park HJ; Qadir AS; Ryoo HM; Woo KM; Baek JH
    J Cell Physiol; 2012 Nov; 227(11):3603-12. PubMed ID: 22307523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of reduced c-Kit signaling on bone marrow adiposity.
    Turner RT; Wong CP; Iwaniec UT
    Anat Rec (Hoboken); 2011 Jul; 294(7):1126-34. PubMed ID: 21634019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.
    Lazarenko OP; Rzonca SO; Suva LJ; Lecka-Czernik B
    Bone; 2006 Jan; 38(1):74-84. PubMed ID: 16137931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
    Gimble JM; Robinson CE; Wu X; Kelly KA; Rodriguez BR; Kliewer SA; Lehmann JM; Morris DC
    Mol Pharmacol; 1996 Nov; 50(5):1087-94. PubMed ID: 8913339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis.
    Ko JY; Wu RW; Kuo SJ; Chen MW; Yeh DW; Ke HC; Wu SL; Wang FS
    Arthritis Rheum; 2012 Apr; 64(4):1204-14. PubMed ID: 22127784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
    Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
    Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells.
    Muruganandan S; Roman AA; Sinal CJ
    J Bone Miner Res; 2010 Feb; 25(2):222-34. PubMed ID: 19929432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
    Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
    Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geranylgeranyl pyrophosphate stimulates PPARγ expression and adipogenesis through the inhibition of osteoblast differentiation.
    Weivoda MM; Hohl RJ
    Bone; 2012 Feb; 50(2):467-76. PubMed ID: 22019459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
    Botolin S; McCabe LR
    J Cell Physiol; 2006 Dec; 209(3):967-76. PubMed ID: 16972249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line.
    Siddhivarn C; Banes A; Champagne C; Riché EL; Weerapradist W; Offenbacher S
    J Periodontal Res; 2007 Oct; 42(5):383-92. PubMed ID: 17760815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression analysis of major lineage-defining factors in human bone marrow cells: effect of aging, gender, and age-related disorders.
    Jiang Y; Mishima H; Sakai S; Liu YK; Ohyabu Y; Uemura T
    J Orthop Res; 2008 Jul; 26(7):910-7. PubMed ID: 18302252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal-less homeobox 5 inhibits adipogenic differentiation through the down-regulation of peroxisome proliferator-activated receptor γ expression.
    Lee HL; Woo KM; Ryoo HM; Baek JH
    J Cell Physiol; 2013 Jan; 228(1):87-98. PubMed ID: 22553076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism.
    Kim WK; Meliton V; Amantea CM; Hahn TJ; Parhami F
    J Bone Miner Res; 2007 Nov; 22(11):1711-9. PubMed ID: 17638575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2).
    Duque G; Macoritto M; Kremer R
    Exp Gerontol; 2004 Mar; 39(3):333-8. PubMed ID: 15036392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program.
    Muruganandan S; Roman AA; Sinal CJ
    Cell Mol Life Sci; 2009 Jan; 66(2):236-53. PubMed ID: 18854943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of PPARγ for the osteoblastic differentiation.
    Viccica G; Francucci CM; Marcocci C
    J Endocrinol Invest; 2010; 33(7 Suppl):9-12. PubMed ID: 20938219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells.
    Yu WH; Li FG; Chen XY; Li JT; Wu YH; Huang LH; Wang Z; Li P; Wang T; Lahn BT; Xiang AP
    Int J Biochem Cell Biol; 2012 Feb; 44(2):377-84. PubMed ID: 22120652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MECHANISMS IN ENDOCRINOLOGY: Bone marrow adiposity and bone, a bad romance?
    Rharass T; Lucas S
    Eur J Endocrinol; 2018 Oct; 179(4):R165-R182. PubMed ID: 30299886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.